ExodusPoint Capital Management’s Axsome Therapeutics AXSM Stock Holding History

ExodusPoint Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3M	Buy	+17,763	New	+$3.07M	0.02%	619
2025 Q2	–	Sell	-52,683	Closed	-$6.14M	–	1466
2025 Q1	$6.14M	Buy	+52,683	New	+$6M	0.06%	348
2024 Q4	–	Sell	-29,479	Closed	-$2.65M	–	1524
2024 Q3	$2.65M	Buy	+29,479	New	+$2.57M	0.02%	619
2023 Q2	–	Sell	-96,684	Closed	-$5.96M	–	1846
2023 Q1	$5.96M	Buy	+96,684	New	+$6.35M	0.05%	455
2022 Q4	–	Sell	-5,444	Closed	-$243K	–	1632
2022 Q3	$243K	Buy	+5,444	New	+$272K	﹤0.01%	1579
2022 Q2	–	Sell	-11,627	Closed	-$481K	–	1927
2022 Q1	$481K	Buy	+11,627	New	+$360K	0.01%	1560
2020 Q3	–	Sell	-36,804	Closed	-$3.03M	–	1740
2020 Q2	$3.03M	Buy	+36,804	New	+$2.83M	0.08%	290
2019 Q3	–	Sell	-21,703	Closed	-$559K	–	1329
2019 Q2	$559K	Sell	21,703 -41,069	-65%	-$823K	0.02%	418
2019 Q1	$893K	Buy	+62,772	New	+$583K	0.07%	208

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ExodusPoint Capital Management's AXSM Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 17,763 shares worth $3M. The stake represents 0.02% of the portfolio and ranks #619 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in AXSM as recently as Q1 2025.

ExodusPoint Capital Management first reported a position in AXSM in Q1 2019 and has held it in 9 quarters since. The position peaked at $6.14M in Q1 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

ExodusPoint Capital Management held 17,763 shares of Axsome Therapeutics worth $3M as of Q1 2026.
Axsome Therapeutics was a new ExodusPoint Capital Management position in Q1 2026.
Axsome Therapeutics made up 0.02% of ExodusPoint Capital Management's portfolio in Q1 2026, its #619 holding.
ExodusPoint Capital Management first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 9 quarters since.
ExodusPoint Capital Management's Axsome Therapeutics position peaked at $6.14M in Q1 2025.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.